Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Autoimmune diseases and reproductive aging.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Field potential recording from rat hippocampus provides a functional evaluation method for assessing demyelination and myelin repair.
Activities of the European multiple sclerosis platform.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation.
Regulation: The FDA is overcautious on consumer genomics.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Dock3 protects myelin in the cuprizone model for demyelination.
Integrative therapies for multiple sclerosis.
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis.

Pages